About: Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A. Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 14 January 2009

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2009 (ast) наукова стаття, опублікована в січні 2009 (uk) scientific article published on 14 January 2009 (en) مقالة علمية نشرت في 14 يناير 2009 (ar)
publication date	wds:Q37116534-28DC29B5-EB81-42A3-A33C-32237ACBB868
publication date	2009-01-14 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37116534-0A9E0702-DA2F-46F9-ADCC-8FDA10357492
language of work or name	English
cites work	wds:Q37116534-039132C7-4C64-4B65-A390-08D158D2CF2A wds:Q37116534-09E789A0-CD78-4FF7-8EBC-55E3D65626F4 wds:Q37116534-0C8F4C83-536D-46AB-9D1C-6B2AB8BA4C52 wds:Q37116534-0D24539B-9098-482B-ABEF-A9B00FEE7A32 wds:Q37116534-0D84BDDF-A94C-49D0-BB83-2C6F2ACB31CA wds:Q37116534-0FC2724A-57BD-401D-9522-E4E3AEE1D6FC wds:Q37116534-155DCB63-493F-45FF-BEE3-2CC07FB590A6 wds:Q37116534-17103FF3-1B0E-4B20-A8E5-4BD2EE8FC935 wds:Q37116534-20753761-6304-4648-AB48-0DBAFA4F1EA1 wds:Q37116534-27586038-61F5-4838-A7EA-CE28EADACF6C wds:Q37116534-2EA3C935-1799-4AD9-AD26-8E109AF1D4CF wds:Q37116534-321292E0-5FA8-47CE-A07A-7FF6FC8CFA34 wds:Q37116534-3238E3BF-EEBC-4BD4-9CC0-5BF660F9793F wds:Q37116534-3C699E0F-8753-4270-8233-68DAE5F2C6A9 wds:Q37116534-53801140-45B5-490E-A393-FBD66246602A wds:Q37116534-56484F03-0A0F-47AC-861F-D9541B1FA7B0 wds:Q37116534-5848125A-51FF-4EA0-85D7-E943DCFAAC4F wds:Q37116534-5AACBCF6-0E1F-4587-A603-21EB611A200A wds:Q37116534-5ECAB1EE-29B4-4506-8ABA-84218AD263CD wds:Q37116534-844CF565-ACA2-4B22-BDD8-E72B879B697B wds:Q37116534-89D56073-CFEC-47DE-AD02-BE359FC64AC1 wds:Q37116534-8D4DBD11-BB12-4E84-8F4E-290EA8484F59 wds:Q37116534-8E88E353-F402-4D93-88D7-326803121EEB wds:Q37116534-98371D60-F7A3-4074-BAB9-196E6E0223D7 wds:Q37116534-99128E2B-3731-4BD5-B473-2ED1C79A88ED wds:Q37116534-A67C63CF-6C42-4FA5-B792-4C7146E76AD5 wds:Q37116534-A6DB5F97-EC7E-4844-A90C-DD91AB33DCFE wds:Q37116534-A75E34CC-A5C9-4C1A-93C9-9F44DEF99467 wds:Q37116534-AE626CA6-C6CE-41A6-B665-04A6E41FB614 wds:Q37116534-AFAD2A2D-0377-4518-8CC0-F0B20DF79FDC wds:Q37116534-B46EF0DC-224F-435E-9A4F-7D4611C1B80C wds:Q37116534-B589661A-94AA-4D18-B984-16D454A2C65C wds:Q37116534-BA6F6D59-6023-4B10-A37E-7F8B6D534CEA wds:Q37116534-BC291084-365F-45D1-A871-64033F4E011A wds:Q37116534-CC772CB0-6D32-48A9-A386-DC787DFAE62D wds:Q37116534-D3D1B7A7-458D-497C-8AD0-F31C37131DB7 wds:Q37116534-DF79554C-B88E-415D-A788-655919041330 wds:Q37116534-ECC23AD7-60B7-4233-8E3B-4A2E5C9E951B wds:Q37116534-F44F8C1E-2213-490E-B441-3ED7EF37FDB1
cites work	Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Epidemiology of invasive pneumococcal disease in urban New South Wales, 1997-1999. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study Six newly recognized types of Streptococcus pneumoniae. Herd immunity and pneumococcal conjugate vaccine: a quantitative model Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies Streptococcus pneumoniae serotype 19A in children, South Korea Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005 Differential effects of pneumococcal vaccines against serotypes 6A and 6C. Pneumococcal bacteremia in hospitalized Israeli adults: epidemiology and resistance to penicillin. Israeli Adult Pneumococcal Bacteremia Group. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age Multiplex opsonophagocytosis assay (MOPA): a useful tool for the monitoring of the 7-valent pneumococcal conjugate vaccine Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006). Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States Assessment of antibody response elicited by a 7-valent pneumococcal conjugate vaccine in pediatric human immunodeficiency virus infection. Pneumococcal Serotype 19F Conjugate Vaccine Induces Cross-Protective Immunity to Serotype 19A in a Murine Pneumococcal Pneumonia Model Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants A four-parameter logistic model for estimating titers of functional multiplexed pneumococcal opsonophagocytic killing assay. Efficiency of a pneumococcal opsonophagocytic killing assay improved by multiplexing and by coloring colonies Invasive pneumococcal disease in the population of Victoria. Pneumococcal bacteraemia and opportunities for prevention.
author name string	wds:Q37116534-1ED48EF2-8BA9-47D7-B12A-C9DD56C4041F

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software